Search Results

61 - 69 of 69 items :

Clear All
Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control

) 6.0 ± 0.7 Child-Pugh score (classes), n [%]:  A 22 [73.3]  B 8 [26.7] Creatinine [μmol/l] 81.7 ± 23.4 ASAT [μkat/l] 1. 1 ± 0.7 ALAT [μkat/l] 0.8 ± 0.6 γGT [μkat/l] 2.3 ± 1.6 αFP [kIE/l] 152.5 ± 310.2 Portal vein thrombosis (yes/no), n [%] 6/29 [17.1/82.9] Bilobar disease, n [%] 11 [31.4] Unilobar disease, n [%:] 24 [68.6] right lobe, n [%] 20 [83.3] Overall number of nodules, n 97 Number of nodules per pt, n 2.8 ± 2.2 Maximum diameter of HCC nodule

Open access
Is endocan a novel potential biomarker of liver steatosis and fibrosis?

–56) 0.002 TC, mmol/L 6.59 (5.04–7.79) 5.78 (4.87–5.79) 0.209 HDL-cholesterol, mmol/L 1.21 (1.01–1.32) 1.19 (0.99–1.34) 0.841 LDL-cholesterol, mmol/L 3.94 (3.07–4.86) 3.40 (2.60–4.37) 0.151 TG, mmol/L 2.36 (1.73–2.84) 2.20 (1.70–2.97) 0.821 AST, U/L 20 (19–24) 20 (17–25) 0.443 ALT, U/L 31 (25–39) 21 (16–28) <0.001 GGT, U/L 23 (16–35) 22 (15–30) 0.552 HsCRP, mg/L 1.81 (0.46–2.94) 1.67 (0.80–3.11) 0.362 Endocan, ng/L 26.0 (14.2–44.3) 44.2 (22.8–92.7) 0.013 Data are given

Open access
Computed tomographic perfusion imaging for the prediction of response and survival to transarterial chemoembolization of hepatocellular carcinoma

Age [years] 68.8 ± 5.8 Sex (M/F), n [%] 17/1 [94.4/5.6] Cirrhosis (yes/no), n [%] 16/2 [88.9/11.1] Aetiology of cirrhosis, n [%] Alcohol 7 [43.8] HBV 3 [18.8] HCV 1 [6.3] Other 5 [31.3] Albumin [g/l] 38.3 ± 5.1 INR 1.2 ± 0.3 Total bilirubin [mmol/l] 23.6 ± 18.8 Child-Pugh score (points) 5.7 ± 0.8 A, n [%] 14 [77.8] B, n [%] 4 [22.2] Creatinine [µmol/l] 87.8 ± 22.8 AST [µkat/l] 1.1 ± 0.9 ALT [µkat/l] 0.9 ± 0.8 γGT [µkat/l] 1

Open access
Anisotropic elastic properties of FexB (x = 1, 2, 3) under pressure. First-principles study

^2 + \left( {2{S_{23}} + {S_{44}}} \right)l_2^3l_3^2 + \left( {2{S_{13}} + {S_{55}}} \right)l_1^2l_3^2$$ (28) For a tetragonal system [ 44 , 45 ]: 1 E = S 11 l 1 4 + l 1 4 + 2 S 13 + S 44 l 1 2 l 3 2 + l 2 2 l 3 2 + S 33 l 3 4 + 2 S 12 + S 66 l 1 2 l 2 2 $$\frac{1}{E} = {S_{11}}\left( {l_1^4 + l_1^4} \right) + \left( {2{S_{13}} + {S_{44}}} \right)\left( {l_1^2l_3^2 + l_2^2l_3^2} \right) + {S_{33}}l_3^4 + \left( {2{S_{12}} + {S_{66}}} \right)l_1^2l_2^2$$ (29) 1 B = S 11 + S 12 + S 13 l 1 2 l 2 2 − 2 S 13 − S 33 l 3 2 $$\frac{1}{B} = \left( {{S_{11}} + {S

Open access
Polymorphism of the IL13 gene may be associated with Uterine leiomyomas in Slovenian women

listed in Table 1 . Table 1 Primer sequences, primer concentrations, annealing temperatures and size of polymerase chain reaction product; restriction enzyme, enzyme concentration and size of DNA fragments after restriction for IL12B (rs6887695). IL12RB1 (rs11575934), 1L23R (rs7517847), 1L4 (rs2070874) and 1L4R (rs1801275). SNP ID (gene) Primer Sequence (5’-3’) Final Concentration of Primer (nM) Ta (°C) PCR Product Size (bp) Restriction Enzyme Enzyme Concentration (units) Allele DNA Fragment Size After Restriction (bp

Open access
Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction

volume of distribution about 47 L. [ 23 , 24 ] Daclatasvir is metabolized by the liver with CYP3A4 being the primary CYP isoform responsible for metabolism. The majority of the drug is eliminated in the feces (53% of the dose as unchanged form and about 7% of the dose was excreted in the urine (primarily as unchanged daclatasvir). Its elimination half-life is about 13 hours and its clearance equals 4.2L/h. Generally, daclatasvir is well tolerated and the most common reported adverse reaction are headache 21 (14%), fatigue 21 (14%), nausea 12 (8%) and diarrhea 7 (5

Open access
Lachish River event monitored for toxicity using bioluminescent reporter organisms

-agar plates (NaCl 5 g L−1, yeast extract 5 g L−1, tryptone 10 g L−1, agar 15 g L−1) supplemented with 50μg/mL kanamycin for DPD1718, or 100 μg/mL ampicillin for the remaining strains. After growth overnight at 37°C, the culture plates were stored at 4°C for use in future experiments. Table 1 List of the bioluminescence bacteria Strain designation E. coli host strain Promoter Stress sensitivity Inducer used in this study Concentration Reference K802NR Psb1075 lasI Nalidixc acid (gorA) Nalidixic acid 100 mg/L ( 23 ) TV1061 RFM443

Open access
Investor-State Dispute Settlement and the Future of the Precautionary Principle

Sadeleer ed., 2007); Lawrence Kogan, What Goes Around Comes Around: How UNCLOS Ratification Will Herald Europe ’s Precautionary Principle as U.S. Law , 7 Santa Clara J. Int’l L. 23 (2009); Lucas Bergkamp, Legal and Administrative Systems: Implications for Precautionary Regulation, in The Reality of Precaution, Comparing Risk Regulation in the United States and Europe 434-79 (Jonathan B. Weiner, Michael D. Rogers, James K. Hammit, & Peter H. Sand eds., 2011); Elisa Vecchione, Is It Possible to Provide Evidence of Insufficient Evidence? The Precautionary Principle at

Open access
Taxation of Controlled Foreign Companies in Context of the OECD/G20 Project on Base Erosion and Profit Shifting as well as the EU Proposal for the Anti-Tax Avoidance Directive – An Interim Nordic Assessment

Danish regime, cf. e.g . L 23 (2008/2009) Forslag til lov om ændring af selskabsskatteloven, fusionsskatteloven og forskellige andre skattelove [governmentbill] (Den.). Some of the regimes include specific rules to address certain questions concerning how to make the computation. For example, both the Swedish and Danish regimes include specific rules on how to determine the entry values for the CFC’s assets. IL 20a:1 (Swe.) and SEL 32 (8) (Den.). Concerning the Norwegian regime, the preparatory remarks explain how to set the entry values for the CFC, Ot. prp. 16 1991

Open access